The Clinical Trials market continues its growth because of increasing R&D expenditure in pharmaceutical and biopharmaceutical companies, globalisation of clinical trials and harmonisation of regulations. However, reductions are expected in the growth of this market because of the increasing cost of drug development and clinical trials.
As the industry grapples with unprecedented challenges, join us for the first-ever Outsourcing in Clinical Trials USA virtual experience (30 Sept-1 Oct) brought to you directly in the comfort of your home! Bringing together experts from across the USA to discuss the latest innovations in outsourcing, technology, regulatory affairs and medical devices, this virtual conference will deliver cutting-edge content on how best to manage outsourcing strategies.
It is becoming clear that the only options are to disrupt or be disrupted: and so this event is focused on examining real-world evidence into innovations and industry trends that you cannot afford to miss.
The event will discuss:
- Drug Development Trends and their Impact on Clinical Trial Execution, Ken Getz, Deputy Director, Research Professor (PCHM), Centre for the Study of Drug Development, Tufts University
- Exploring How Best to Manage a Shifting Portfolio, Kristine Koontz, Head of US Clinical Operations, GSK
- Site engagement during the site feasibility process and the impact on study start-Up timelines, Sandeep Menon, Senior Vice President and Head of Early Clinical Development, Pfizer
Our two-day event will be fully online and free to attend, allowing you to connect with others across the industry. Visit our website to learn more about the event and book your place now!